Multiple Manufacturers

ARRANON

Manufacturer:

Multiple Manufacturers

Arranon HCPCS:

J9261

HCPCS Code Descriptor:

Injection, nelarabine, 50 mg

Category:

J Code

Arranon NDCs:

71288-0165-53, 70710-1839-08, 70710-1726-08, 81927-0111-06, 70121-1743-04, 43598-0142-06, 00078-0683-61, 43598-0142-11, 70710-1839-01, 70710-1726-01, 81927-0111-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

43598-0142-06, 43598-0142-11

About Arranon:

ARRANON is an Oncology drug manufactured by Novartis and administered via the Intravenous route of administration. The J Code: J9261 is aligned to the drug ARRANON.

ACCESS PRICING AND MORE BY REGISTERING

J9261 Added Date:

January 1, 2007

J9261 Effective Date:

January 1, 2007

J9261 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Arranon billing and coding information.
Arranon patient assistance information can be found through Novartis Patient Support at the URL: https://www.patient.novartisoncology.com/financial-assistance/pano/
ARRANON prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for ARRANON. Please check back in a few weeks.